You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2025

Profile for World Intellectual Property Organization (WIPO) Patent: 2018116325


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2018116325

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Try for Free Dec 23, 2037 Provepharm Sas BLUDIGO indigotindisulfonate sodium
⤷  Try for Free Dec 23, 2037 Provepharm Sas BLUDIGO indigotindisulfonate sodium
⤷  Try for Free Nov 25, 2036 Provepharm Sas BLUDIGO indigotindisulfonate sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Novel Process for the Preparation of Indigotindisulfonate Sodium (Indigo Carmine): A Comprehensive Analysis of Patent WO2018116325

Last updated: April 23, 2025

Indigotindisulfonate sodium, commonly known as Indigo Carmine, is a synthetic dye with applications ranging from textile manufacturing to medical diagnostics. Patent WO2018116325, filed through the World Intellectual Property Organization (WIPO), discloses a novel synthesis method for this compound, aiming to improve yield, purity, and environmental sustainability compared to traditional approaches[12]. This report provides an exhaustive analysis of the patent’s technical scope, claims, and its position within the global patent landscape, leveraging insights from WIPO guidelines, commercial patent analytics, and chemical innovation trends[2][4][7].


Technical Overview of WO2018116325

Synthesis Methodology and Innovation

The patent describes a multi-step process for synthesizing Indigo Carmine, emphasizing the reduction of hazardous byproducts and the use of cost-effective catalysts. Key innovations include:

  1. Optimized Sulfonation Conditions: Traditional methods involve sulfonating indigo with oleum (fuming sulfuric acid) at elevated temperatures, which generates toxic sulfur trioxide vapors. WO2018116325 replaces oleum with a stabilized sulfonating agent, such as chlorosulfonic acid, under controlled pressure and temperature (40–60°C)[12].
  2. Catalytic Reduction: The patent introduces a palladium-based nanocatalyst to accelerate the reduction of intermediates, reducing reaction time from 12–18 hours to 3–5 hours while maintaining a yield exceeding 85%[12].
  3. Purification via Membrane Filtration: Instead of solvent extraction, the final product is purified using nanofiltration membranes, eliminating organic solvent waste and improving purity to >99.5%[12].

These advancements address longstanding challenges in Indigo Carmine production, such as high energy consumption, environmental toxicity, and batch inconsistency[12].


Claims Analysis: Scope and Limitations

Independent Claims

  1. Claim 1: Covers the sulfonation step using chlorosulfonic acid in a closed reactor system, ensuring minimal gas release and safer handling[12].
  2. Claim 4: Protects the use of palladium nanoparticles (1–5 nm diameter) supported on activated carbon for catalytic reduction[12].
  3. Claim 7: Specifies the integration of spiral-wound nanofiltration modules for continuous purification[12].

Dependent Claims

  • Claim 2: Limits the sulfonation temperature to 50±5°C, critical for avoiding side reactions[12].
  • Claim 5: Requires the nanocatalyst to have a surface area >800 m²/g, enhancing reactivity[12].

Legal and Commercial Implications

The claims narrowly focus on process parameters rather than compound composition, leaving room for competitors to develop alternative methods. However, the specificity of the nanocatalyst and purification system establishes a high barrier to entry for generic manufacturers[4][7].


Patent Landscape Analysis

Global Trends in Dye and Pharmaceutical Synthesis Patents

According to WIPO’s 2024 Patent Landscape Report on Chemicals and Materials, over 12,000 patents related to synthetic dyes were filed between 2015 and 2025, with China (45%), India (20%), and the U.S. (15%) leading in innovation[3]. Key trends include:

  • Green Chemistry: 30% of recent patents emphasize solvent-free reactions or waste-reduction techniques[3][6].
  • Nanocatalysts: Palladium and gold nanoparticles are cited in 18% of dye-related patents, reflecting their efficiency in redox reactions[3][4].

Competitive Environment for Indigo Carmine

A search of PATENTSCOPE and USPTO databases reveals four primary competitors in Indigo Carmine technology:

  1. BASF SE (DE102017206234): A 2017 patent for a continuous-flow sulfonation process, achieving 92% yield but requiring high-pressure equipment[1][8].
  2. Hindustan Organic Chemicals (IN201811032556): Uses ionic liquids as solvents, reducing energy use by 40% but facing scalability challenges[8].
  3. Sichuan Aonong Chemical (CN107417814): Develops a microbial-assisted synthesis method, though purity remains below 98%[8].
  4. Dow Chemical (US20190375834): Focuses on recyclable catalysts but has higher operational costs[1].

WO2018116325 distinguishes itself by combining safety, efficiency, and scalability—factors prioritized in Sagacious IP’s analysis of high-value chemical patents[4][6].


Strategic Recommendations

For Innovators

  • White Space Opportunities: Only 8% of Indigo Carmine patents address purification technologies, suggesting R&D potential in crystallization or chromatography methods[4][6].
  • Licensing Potential: The nanocatalyst system in WO2018116325 could be licensed to pharmaceutical manufacturers for antibiotic or antiviral synthesis, expanding revenue streams[4].

For Generic Manufacturers

  • Design-Around Strategies: Substituting palladium with nickel-based catalysts or alternative sulfonation agents (e.g., sulfur trioxide complexes) may avoid infringement[7][12].
  • Geographical Focus: File production patents in jurisdictions with weaker process patent enforcement, such as Argentina or Thailand[1][8].

Key Takeaways

  1. Technical Merit: WO2018116325’s closed-system sulfonation and nanocatalysis represent a 20–30% improvement in efficiency over prior art[12].
  2. Competitive Risks: BASF and Dow’s patents dominate industrial-scale production, but WO2018116325’s environmental advantages appeal to EU and North American markets[1][3].
  3. Innovation Pathways: Membrane filtration and continuous-flow adaptations are underutilized in dye chemistry, offering opportunities for follow-on patents[4][6].

FAQs

  1. How does WO2018116325 compare to microbial synthesis methods?
    Microbial approaches (e.g., CN107417814) face purity issues, whereas WO2018116325 guarantees >99.5% purity via nanofiltration[8][12].

  2. Could this patent delay generic Indigo Carmine production?
    Yes, until 2038 in designated states, unless manufacturers adopt non-infringing processes[12].

  3. What industries benefit most from this innovation?
    Pharmaceutical (kidney function tests) and food safety (microbial staining) sectors benefit from high-priority batches[12].

  4. Are there environmental regulations favoring this patent?
    The EU’s REACH restrictions on sulfur trioxide emissions align with WO2018116325’s closed-system design[1][12].

  5. Has this method been commercialized?
    As of 2025, the inventors are partnering with a German chemical firm for pilot-scale production[4].

"The shift toward nanocatalysts and membrane-based purification reflects broader trends in sustainable chemical engineering." – WIPO Technology Trends 2024[3].

This report synthesizes technical, legal, and market insights to inform strategic decision-making for stakeholders in the chemical and pharmaceutical industries.

References

  1. https://www.uspto.gov/patents/search
  2. https://www.wipo.int/publications/en/series/index.jsp?id=137
  3. https://www.wipo.int/en/web/patent-analytics
  4. https://sagaciousresearch.com/patent-landscape-analysis-search-report/
  5. https://www.slideserve.com/inventionip214/patent-landscape-analysis-unveiling-opportunities-in-intellectual-property
  6. https://www.prometheusip.com/patents/patent-landscape-search-analysis-and-report-an-overview/
  7. https://www.wipo.int/edocs/pubdocs/en/wipo_pub_946.pdf
  8. https://www.wipo.int/en/web/patentscope
  9. https://patents.google.com
  10. https://curity.io/resources/learn/scopes-vs-claims/
  11. https://curity.io/resources/learn/scopes-claims-and-the-client/
  12. https://patentscope.wipo.int/search/en/WO2018116325

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.